{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T16:53:00Z","timestamp":1779900780806,"version":"3.53.1"},"reference-count":53,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,1]]},"abstract":"<jats:sec>\n                  <jats:title>BACKGROUND:<\/jats:title>\n                  <jats:p>Health administrative data offer a vital source of data on maternal prenatal opioid exposure (POE). The impact of different methods to estimate POE, especially combining maternal and newborn records, is not known.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS:<\/jats:title>\n                  <jats:p>This population-based cross-sectional study included 454\u2009746 hospital births with linked administrative data in Ontario, Canada, in 2014\u20132017. POE ascertainment included 3 sources: (1) prenatal opioid prescriptions, (2) maternal opioid-related hospital records, and (3) newborn hospital records with neonatal abstinence syndrome (NAS). Positive percent agreement was calculated comparing cases identified by source, and a comprehensive method was developed combining all 3 sources. We replicated common definitions of POE and NAS from existing literature and compared both number of cases ascertained and maternal socio-demographics and medical history using the comprehensive method.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS:<\/jats:title>\n                  <jats:p>Using all 3 data sources, there were 9624 cases with POE (21.2 per 1000 births). Among these, positive percent agreement (95% confidence interval) was 79.0% (78.2\u201379.8) for prenatal opioid prescriptions, 19.0% (18.2\u201319.8) for maternal opioid-related hospital records, and 44.7% (43.7\u201345.7) for newborn NAS. Compared with other definitions, our comprehensive method identified up to 523% additional cases. Contrasting ascertainment with maternal opioid-related hospital records, newborn NAS, and prenatal opioid prescriptions respective rates of maternal low income were 57%, 48%, and 39%; mental health hospitalization history was 33%, 28%, and 17%; and infant discharge to social services was 8%, 13%, and 5%.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS:<\/jats:title>\n                  <jats:p>Combining prenatal opioid prescriptions and maternal and newborn opioid-related hospital codes improves identification of a broader population of mothers and infants with POE.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/peds.2020-018507","type":"journal-article","created":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T09:26:11Z","timestamp":1609233971000},"source":"Crossref","is-referenced-by-count":16,"title":["Identification of Prenatal Opioid Exposure Within Health Administrative Databases"],"prefix":"10.1542","volume":"147","author":[{"given":"Andi","family":"Camden","sequence":"first","affiliation":[{"name":"Dalla Lana School of Public Health, University of Toronto, Toronto, Canada;"},{"name":"ICES, Toronto, Canada;"},{"name":"The Hospital for Sick Children, Toronto, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel G.","family":"Ray","sequence":"additional","affiliation":[{"name":"ICES, Toronto, Canada;"},{"name":"The Hospital for Sick Children, Toronto, Canada;"},{"name":"Department of Obstetrics and Gynaecology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"To","sequence":"additional","affiliation":[{"name":"Dalla Lana School of Public Health, University of Toronto, Toronto, Canada;"},{"name":"ICES, Toronto, Canada;"},{"name":"The Hospital for Sick Children, Toronto, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Gomes","sequence":"additional","affiliation":[{"name":"ICES, Toronto, Canada;"},{"name":"Li Ka Shing Knowledge Institute, St. Michael\u2019s Hospital, Toronto, Canada; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Bai","sequence":"additional","affiliation":[{"name":"ICES, Toronto, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Guttmann","sequence":"additional","affiliation":[{"name":"Dalla Lana School of Public Health, University of Toronto, Toronto, Canada;"},{"name":"ICES, Toronto, Canada;"},{"name":"The Hospital for Sick Children, Toronto, Canada;"},{"name":"Edwin S.H. Leong Centre for Healthy Children, University of Toronto, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2021,1,1]]},"reference":[{"issue":"3","key":"2021120906370300900_B1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jogc.2016.11.009","article-title":"Infants born to opioid-dependent women in Ontario, 2002\u20132014","volume":"39","author":"Brogly","year":"2017","journal-title":"J Obstet Gynaecol Can"},{"issue":"1","key":"2021120906370300900_B2","doi-asserted-by":"crossref","first-page":"E55","DOI":"10.9778\/cmajo.20140065","article-title":"Neonatal opioid withdrawal and antenatal opioid prescribing","volume":"3","author":"Turner","year":"2015","journal-title":"CMAJ Open"},{"issue":"31","key":"2021120906370300900_B3","doi-asserted-by":"crossref","first-page":"845","DOI":"10.15585\/mmwr.mm6731a1","article-title":"Opioid use disorder documented at delivery hospitalization - United States, 1999\u20132014","volume":"67","author":"Haight","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2021120906370300900_B4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.drugalcdep.2017.12.019","article-title":"Trends in incidence of neonatal abstinence syndrome in Canada and associated healthcare resource utilization","volume":"185","author":"Filteau","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"2021120906370300900_B5","doi-asserted-by":"crossref","first-page":"906723","DOI":"10.1155\/2014\/906723","article-title":"Maternal opioid drug use during pregnancy and its impact on perinatal morbidity, mortality, and the costs of medical care in the United States","volume":"2014","author":"Whiteman","year":"2014","journal-title":"J Pregnancy"},{"key":"2021120906370300900_B6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ynstr.2018.08.005","article-title":"Early life stress and environmental influences on the neurodevelopment of children with prenatal opioid exposure","volume":"9","author":"Conradt","year":"2018","journal-title":"Neurobiol Stress"},{"issue":"5\u20136","key":"2021120906370300900_B7","first-page":"e616","article-title":"Opioid use in pregnancy and parenting: an Indigenous-based, collaborative framework for Northwestern Ontario","volume":"108","author":"Jumah","year":"2018","journal-title":"Can J Public Health"},{"issue":"2","key":"2021120906370300900_B8","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jamapediatrics.2016.3750","article-title":"Rural and urban differences in neonatal abstinence syndrome and maternal opioid use, 2004 to 2013","volume":"171","author":"Villapiano","year":"2017","journal-title":"JAMA Pediatr"},{"issue":"2","key":"2021120906370300900_bib54","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.siny.2019.01.012","article-title":"After NAS","volume":"24","author":"Oei","year":"2019","journal-title":"Semin Fetal Neonatal Med"},{"issue":"1","key":"2021120906370300900_B10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41572-018-0045-0","article-title":"Neonatal abstinence syndrome","volume":"4","author":"Coyle","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"2021120906370300900_B11","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1542\/peds.2014-3299","article-title":"Prescription opioid epidemic and infant outcomes","volume":"135","author":"Patrick","year":"2015","journal-title":"Pediatrics"},{"issue":"suppl 2","key":"2021120906370300900_B12","first-page":"5","article-title":"Birth and neonatal outcomes following opioid use in pregnancy: a Danish population-based study","volume":"9","author":"N\u00f8rgaard","year":"2015","journal-title":"Subst Abuse"},{"issue":"10","key":"2021120906370300900_B13","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/jp.2017.106","article-title":"Neonatal abstinence syndrome and early childhood morbidity and mortality in Washington state: a retrospective cohort study","volume":"37","author":"Witt","year":"2017","journal-title":"J Perinatol"},{"issue":"4","key":"2021120906370300900_B14","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2014-2767","article-title":"Reasons for rehospitalization in children who had neonatal abstinence syndrome","volume":"136","author":"Uebel","year":"2015","journal-title":"Pediatrics"},{"issue":"10","key":"2021120906370300900_B15","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1542\/hpeds.2015-0024","article-title":"Risk of hospital readmission among infants with neonatal abstinence syndrome","volume":"5","author":"Patrick","year":"2015","journal-title":"Hosp Pediatr"},{"issue":"11","key":"2021120906370300900_B16","doi-asserted-by":"crossref","first-page":"e1002974","DOI":"10.1371\/journal.pmed.1002974","article-title":"Long-term mortality in mothers of infants with neonatal abstinence syndrome: a population-based parallel-cohort study in England and Ontario, Canada","volume":"16","author":"Guttmann","year":"2019","journal-title":"PLoS Med"},{"issue":"2","key":"2021120906370300900_B17","doi-asserted-by":"crossref","first-page":"e20183664","DOI":"10.1542\/peds.2018-3664","article-title":"Neonatal abstinence syndrome and associated neonatal and maternal mortality and morbidity","volume":"144","author":"Lisonkova","year":"2019","journal-title":"Pediatrics"},{"issue":"3","key":"2021120906370300900_B18","doi-asserted-by":"crossref","first-page":"e20190128","DOI":"10.1542\/peds.2019-0128","article-title":"Prenatal opioid exposure: neurodevelopmental consequences and future research priorities","volume":"144","author":"Conradt","year":"2019","journal-title":"Pediatrics"},{"issue":"1","key":"2021120906370300900_B19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/AOG.0000000000002054","article-title":"Opioid use in pregnancy, neonatal abstinence syndrome, and childhood outcomes: executive summary of a joint workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and Gynecologists, American Academy of Pediatrics, Society for Maternal-Fetal Medicine, Centers for Disease Control and Prevention, and the March of Dimes Foundation","volume":"130","author":"Reddy","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2021120906370300900_B20","doi-asserted-by":"crossref","first-page":"e20183801","DOI":"10.1542\/peds.2018-3801","article-title":"Public health surveillance of prenatal opioid exposure in mothers and infants","volume":"143","author":"Honein","year":"2019","journal-title":"Pediatrics"},{"issue":"8","key":"2021120906370300900_B21","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1089\/jwh.2019.7943","article-title":"Surveillance for emerging threats to pregnant women and infants","volume":"28","author":"Frey","year":"2019","journal-title":"J Womens Health (Larchmt)"},{"issue":"9","key":"2021120906370300900_B22","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2105\/AJPH.2019.305170","article-title":"Standardization of state definitions for neonatal abstinence syndrome surveillance and the opioid crisis","volume":"109","author":"Chiang","year":"2019","journal-title":"Am J Public Health"},{"key":"2021120906370300900_B23","doi-asserted-by":"crossref","first-page":"h2298","DOI":"10.1136\/bmj.h2298","article-title":"Antipsychotic drug use in pregnancy: high dimensional, propensity matched, population based cohort study","volume":"350","author":"Vigod","year":"2015","journal-title":"BMJ"},{"issue":"5","key":"2021120906370300900_B24","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/1471-0528.12567","article-title":"Maternal and newborn outcomes among women with schizophrenia: a retrospective population-based cohort study","volume":"121","author":"Vigod","year":"2014","journal-title":"BJOG"},{"issue":"4","key":"2021120906370300900_B25","article-title":"Linking the narcotics monitoring system database to quantify the contribution of prescribed and non-prescribed opioids to opioid overdoses in Ontario, Canada","volume":"3","author":"Martins","year":"2018","journal-title":"Int J Popul Data Sci"},{"issue":"1","key":"2021120906370300900_B26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12911-016-0375-3","article-title":"Describing the linkages of the immigration, refugees and citizenship Canada permanent resident data and vital statistics death registry to Ontario\u2019s administrative health database","volume":"16","author":"Chiu","year":"2016","journal-title":"BMC Med Inform Decis Mak"},{"issue":"12","key":"2021120906370300900_B27","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"12","author":"von Elm","year":"2014","journal-title":"Int J Surg"},{"issue":"10","key":"2021120906370300900_B28","doi-asserted-by":"crossref","first-page":"e1001885","DOI":"10.1371\/journal.pmed.1001885","article-title":"The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement","volume":"12","author":"Benchimol","year":"2015","journal-title":"PLoS Med"},{"key":"2021120906370300900_B29","author":"Statistics Canada"},{"key":"2021120906370300900_B30","author":"Statistics Canada"},{"issue":"2","key":"2021120906370300900_B31","first-page":"1135","article-title":"ICES: data, discovery, better health","volume":"4","author":"Schull","year":"2020","journal-title":"Int J Popul Data Sci"},{"key":"2021120906370300900_B32","volume-title":"Perinatal Health Indicators for Canada 2017: A Report from the Canadian Perinatal Surveillance System","author":"Public Health Agency of Canada","year":"2017","edition":"December 2019"},{"issue":"9","key":"2021120906370300900_B33","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jogc.2017.03.108","article-title":"No. 347-obstetric management at borderline viability","volume":"39","author":"Ladhani","year":"2017","journal-title":"J Obstet Gynaecol Can"},{"issue":"18","key":"2021120906370300900_B34","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.2012.3951","article-title":"Neonatal abstinence syndrome and associated health care expenditures: United States, 2000\u20132009","volume":"307","author":"Patrick","year":"2012","journal-title":"JAMA"},{"issue":"1","key":"2021120906370300900_B35","doi-asserted-by":"crossref","first-page":"F26","DOI":"10.1136\/archdischild-2015-308948","article-title":"Neonatal drug withdrawal syndrome: cross-country comparison using hospital administrative data in England, the USA, Western Australia and Ontario, Canada","volume":"101","author":"Davies","year":"2016","journal-title":"Arch Dis Child Fetal Fetal Neonatal Ed"},{"issue":"5","key":"2021120906370300900_B36","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.acap.2010.06.008","article-title":"The ripples of adolescent motherhood: social, educational, and medical outcomes for children of teen and prior teen mothers","volume":"10","author":"Jutte","year":"2010","journal-title":"Acad Pediatr"},{"issue":"4","key":"2021120906370300900_B37","first-page":"21","article-title":"Birth outcomes by neighbourhood income and recent immigration in Toronto","volume":"18","author":"Urquia","year":"2007","journal-title":"Health Rep"},{"issue":"6","key":"2021120906370300900_B38","doi-asserted-by":"crossref","first-page":"e20181416","DOI":"10.1542\/peds.2018-1416","article-title":"Maternal intellectual or developmental disability and newborn Discharge to protective services","volume":"142","author":"Brown","year":"2018","journal-title":"Pediatrics"},{"key":"2021120906370300900_B39","volume-title":"Mental Health and Addictions System Performance in Ontario: A Baseline Scorecard. Chart Pack","author":"Team","year":"2018"},{"issue":"1","key":"2021120906370300900_B40","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/1471-2474-15-216","article-title":"An administrative data validation study of the accuracy of algorithms for identifying rheumatoid arthritis: the influence of the reference standard on algorithm performance","volume":"15","author":"Widdifield","year":"2014","journal-title":"BMC Musculoskelet Disord"},{"key":"2021120906370300900_B41","doi-asserted-by":"crossref","first-page":"h2102","DOI":"10.1136\/bmj.h2102","article-title":"Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study","volume":"350","author":"Desai","year":"2015","journal-title":"BMJ"},{"issue":"3","key":"2021120906370300900_B42","doi-asserted-by":"crossref","first-page":"512","DOI":"10.2337\/diacare.25.3.512","article-title":"Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm","volume":"25","author":"Hux","year":"2002","journal-title":"Diabetes Care"},{"issue":"7","key":"2021120906370300900_B43","doi-asserted-by":"crossref","first-page":"e184571","DOI":"10.1001\/jamanetworkopen.2018.4571","article-title":"Prevalence of severe maternal morbidity and factors associated with maternal mortality in Ontario, Canada","volume":"1","author":"Ray","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"6","key":"2021120906370300900_B44","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1161\/HYPERTENSIONAHA.109.139279","article-title":"Validation of a case definition to define hypertension using administrative data","volume":"54","author":"Quan","year":"2009","journal-title":"Hypertension"},{"issue":"6","key":"2021120906370300900_B45","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1155\/2009\/963098","article-title":"Identifying patients with physician-diagnosed asthma in health administrative databases","volume":"16","author":"Gershon","year":"2009","journal-title":"Can Respir J"},{"issue":"6","key":"2021120906370300900_B46","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1080\/03610910902859574","article-title":"Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research","volume":"38","author":"Austin","year":"2009","journal-title":"Commun Stat Simul Comput"},{"issue":"12","key":"2021120906370300900_B47","doi-asserted-by":"crossref","first-page":"e1002980","DOI":"10.1371\/journal.pmed.1002980","article-title":"Maternal prescribed opioid analgesic use during pregnancy and associations with adverse birth outcomes: a population-based study","volume":"16","author":"Sujan","year":"2019","journal-title":"PLoS Med"},{"issue":"2","key":"2021120906370300900_B48","doi-asserted-by":"crossref","first-page":"E517","DOI":"10.9778\/cmajo.20160102","article-title":"Opioid use during pregnancy: a population-based cohort study","volume":"5","author":"Falk","year":"2017","journal-title":"CMAJ Open"},{"issue":"1","key":"2021120906370300900_B52","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/jrh.12329","article-title":"Maternal opioid use disorder and neonatal abstinence syndrome among rural US residents, 2007\u20132014","volume":"35","author":"Kozhimannil","year":"2019","journal-title":"J Rural Health"},{"issue":"5","key":"2021120906370300900_B53","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/AOG.0000000000003231","article-title":"Medication-assisted treatment use among pregnant women with opioid use disorder","volume":"133","author":"Krans","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"2","key":"2021120906370300900_B49","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/GRF.0000000000000098","article-title":"Caring for opioid-dependent pregnant women: prenatal and postpartum care considerations","volume":"58","author":"Krans","year":"2015","journal-title":"Clin Obstet Gynecol"},{"issue":"4","key":"2021120906370300900_B50","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1097\/AOG.0000000000002881","article-title":"Prenatal treatment and outcomes of women with opioid use disorder","volume":"132","author":"Brogly","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"2","key":"2021120906370300900_B51","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2011-3212","article-title":"Neonatal drug withdrawal","volume":"129","author":"Hudak","year":"2012","journal-title":"Pediatrics"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2020-018507\/1082213\/peds_2020018507.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2020-018507\/1082213\/peds_2020018507.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T00:57:04Z","timestamp":1639097824000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/147\/1\/e2020018507\/33418\/Identification-of-Prenatal-Opioid-Exposure-Within"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,1]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1,1]]},"published-print":{"date-parts":[[2021,1,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2020-018507","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,1]]},"article-number":"e2020018507"}}